- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
8
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
8 companies
TTY Biopharm
Market Cap: NT$19.1b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$79.20
7D
2.7%
1Y
4.2%
Cenra
Market Cap: NT$5.1b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$35.90
7D
1.8%
1Y
5.9%
Maxigen Biotech
Market Cap: NT$3.7b
Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$40.80
7D
1.0%
1Y
-5.1%
Allied Biotech
Market Cap: NT$2.4b
Engages in the manufacture and sale of carotenoids worldwide.
1780
NT$25.00
7D
6.6%
1Y
43.3%
Vetnostrum Animal Health
Market Cap: NT$2.3b
Engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed.
6936
NT$32.40
7D
0.9%
1Y
-7.8%
TSH Biopharm
Market Cap: NT$1.9b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$50.10
7D
-1.6%
1Y
5.7%
Chi Sheng Pharma & Biotech
Market Cap: NT$1.8b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$30.10
7D
0.2%
1Y
-6.6%
Bioray Biotech
Market Cap: NT$575.4m
Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$17.75
7D
2.6%
1Y
-30.4%